Empagliflozin causes nephrotoxicity in patients on guideline-directed medical therapy via urokinase-type plasminogen activator: An in silico approach
Author:
Philip Anu,Dwivedi Prarambh S. R.,Shastry C. S.,Utagi Basavaraj
Publisher
Ukaaz Publications